Keywords: رادیوم 223; Abscopal effect; mCRPC; Positron emission tomography; Prostate-specific membrane antigen; Radium-223;
مقالات ISI رادیوم 223 (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: رادیوم 223; ALSYMPCA; Bone metastases; Castration-resistant prostate cancer; Long-term safety; Radium-223; Follow-up;
Keywords: رادیوم 223; Prostate cancer; Castration-resistant prostate cancer with bone metastases; Treatment; Metastases; Radium-223; Cáncer de próstata; Cáncer de próstata resistente a la castración con metástasis óseas; Tratamiento; Metástasis; Radio-223;
Keywords: رادیوم 223; Breast cancer; Prostate cancer; Lung cancer; Bone metastases; Radionuclide therapy; Radium-223; PET;
Keywords: رادیوم 223; Bone metastases; Flare phenomenon; Radium-223; Targeted alpha therapy; Treatment monitoring;
Keywords: رادیوم 223; Targeted Alpha Therapy; Radiobiology; Radium-223; Bone metastasis; Prostate Cancer;
Keywords: رادیوم 223; Prostate cancer; Bisphosphonates; Abiraterone acetate; Denosumab; Zoledronic acid; Enzalutamide; Radium-223;
Keywords: رادیوم 223; Bone mineral density; bone-targeted therapy; denosumab; prostate cancer; radium-223; zoledronic acid;
Keywords: رادیوم 223; Radium-223; Alpha emitters; Metastatic castration-resistant prostate cancer; Bone metastases; Radiopharmaceuticals; Survival;
Keywords: رادیوم 223; CRPC; Novel treatments; Abiraterone; Enzalutamide; Cabazitaxel; Sipuleucel T; Radium-223;
Keywords: رادیوم 223; Castration-resistant prostate cancer; Enzalutamide; Abiraterone; Radium-223; Cabazitaxel; Docetaxel; Bone metastases;
Keywords: رادیوم 223; Radium-223; Bone; Prostate cancer; Stroma; Radiopharmaceuticals; Samarium-153; Strontium-89; Alpha particle; Targeted therapy;
Radio-223 en la secuencia terapéutica del cáncer de próstata resistente a la castración metastásico
Keywords: رادیوم 223; Cáncer de próstata; Cáncer de próstata resistente a la castración con metástasis óseas; Tratamiento; Metástasis; Radio-223; Prostate cancer; Castration-resistant prostate cancer with bone metastases; Treatment; Metastases; Radium-223;
Acute Myeloid Leukemia After Radium-223 Therapy: Case Report
Keywords: رادیوم 223; AML; Microenvironment; Prostate Cancer; Radium-223; Secondary leukemia;
Effect of radium-223 dichloride (Ra-223) on hospitalisation: An analysis from the phase 3 randomised Alpharadin in Symptomatic Prostate Cancer Patients (ALSYMPCA) trial
Keywords: رادیوم 223; Radium-223; Metastatic castration-resistant prostate cancer (mCRPC); Symptomatic skeletal event; Hospitalisation; Health care resource use;
Acute Promyelocytic Leukemia After Treatment of Metastatic Castration-Resistant Prostate Cancer With Radium-223
Keywords: رادیوم 223; Acute promyelocytic leukemia; Bone metastases; Castrate-resistant prostate cancer; Leukemia; Radium-223;
Molecular Imaging in the Evaluation of 6 Doses of Ra-223 in High-Grade Prostate Cancer: Case Report
Keywords: رادیوم 223; High-grade prostate cancer; NaF; PET/CT; PSMA; Radium-223;
Radiopharmaceuticals in the elderly cancer patient: Practical considerations, with a focus on prostate cancer therapy: A position paper from the International Society of Geriatric Oncology Task Force
Keywords: رادیوم 223; Radionuclide imaging; Radionuclide therapy; Elderly; Comorbidities; Prostate cancer; Molecular imaging; Radium-223;
Cherenkov light production from the α-emitting decay chains of 223Ra, 212Pb, and 149Tb for Cherenkov Luminescence Imaging
Keywords: رادیوم 223; Cherenkov imaging; Radium-223; Lead-212; Terbium-149;
Prostate-Specific Antigen Flare Phenomenon During 223Ra-Dichloride Treatment for Bone Metastatic Castration-Resistant Prostate Cancer: A Case Report
Keywords: رادیوم 223; Bone metastases; mCRPC; PSA; Radionuclide therapy; Radium-223;
Synthesis and characterization of lanthanum phosphate nanoparticles as carriers for 223Ra and 225Ra for targeted alpha therapy
Keywords: رادیوم 223; Targeted alpha therapy; Targeted radioimmunotherapy; Radioactive nanoparticles; Lanthanum phosphate; Actinium-225; Radium-223; Radium-225; in-vitro retention; in-vivo generators
225Ac and 223Ra production via 800 MeV proton irradiation of natural thorium targets
Keywords: رادیوم 223; Actinium-225; Radium-223; Cross section; Yield; Proton irradiation; Thorium target
New treatment options for patients with metastatic castration-resistant prostate cancer
Keywords: رادیوم 223; Chemotherapy; Metastatic castration-resistant prostate cancer; Treatment paradigm; Docetaxel; Cabazitaxel; Sipuleucel-T; Mitoxantrone; Abiraterone; Denosumab; Radium-223
Proton-induced cross sections relevant to production of 225Ac and 223Ra in natural thorium targets below 200 MeV
Keywords: رادیوم 223; Actinium-225; Radium-223; Cross section; Yield; Proton irradiation; Thorium target
Bone-targeting radiopharmaceuticals for the treatment of prostate cancer with bone metastases
Keywords: رادیوم 223; Bone metastases; Castration-resistant prostate cancer; Radiopharmaceuticals; Radium-223; Samarium-153; Strontium-89